Statistical approach to COVID-19 clinical trials aims to accelerate drug approval process
In response to the COVID-19 pandemic, researchers from the Massachusetts Institute of Technology have published a pair of studies in a COVID-19 special issue of the Harvard Data Science Review, freely available via open access, ...